Cargando…

The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905

OBJECTIVE: To explore the association of a functional germline variant in the 3′-UTR of KRAS with endometrial cancer risk, as well as the association of microRNA (miRNA) signatures and the KRAS-variant with clinical characteristics and survival outcomes in two prospective RTOG endometrial cancer tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Larissa J., Ratner, Elena, Uduman, Mohamed, Winter, Kathryn, Boeke, Marta, Greven, Kathryn M., King, Stephanie, Burke, Thomas W., Underhill, Kelly, Kim, Harold, Boulware, Raleigh J., Yu, Herbert, Parkash, Vinita, Lu, Lingeng, Gaffney, David, Dicker, Adam P., Weidhaas, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986055/ https://www.ncbi.nlm.nih.gov/pubmed/24732316 http://dx.doi.org/10.1371/journal.pone.0094167

Ejemplares similares

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
por: Wu, Ying, et al.
Publicado: (2021)

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis
por: Wang, Hao, et al.
Publicado: (2016)

Web based pathology assessment in RTOG 98-04
por: Woodward, Wendy A, et al.
Publicado: (2014)

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610
por: Pan, Larry, et al.
Publicado: (2013)

A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer
por: Ratner, Elena S., et al.
Publicado: (2011)

Effect of RTOG breast/chest wall guidelines on dose‐volume histogram parameters
por: Rudra, Sonali, et al.
Publicado: (2014)

Clinical and dosimetric experience with MammoSite‐based brachytherapy under the RTOG 0413 protocol
por: Wojcicka, Jadwiga B., et al.
Publicado: (2007)

RTOG 0518: Randomized Phase III Trial to Evaluate Zoledronic Acid for Prevention of Osteoporosis and Associated Fractures in Prostate Cancer Patients
por: Kachnic, Lisa A., et al.
Publicado: (2013)

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330
por: Kane, J. M., et al.
Publicado: (2012)

Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714
por: Chow, Edward, et al.
Publicado: (2011)

Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer
por: Liskamp, C.P., et al.
Publicado: (2020)

The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC
por: Weidhaas, Joanne B., et al.
Publicado: (2023)

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
por: Feng, Felix Y., et al.
Publicado: (2021)

Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China
por: Liang, Shao-Bo, et al.
Publicado: (2017)

Evaluation of Acuros XB algorithm based on RTOG 0813 dosimetric criteria for SBRT lung treatment with RapidArc
por: Rana, Suresh, et al.
Publicado: (2014)

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
por: Nichols, R. Charles, et al.
Publicado: (2017)

An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores
por: Pérez, Isaura Fernández, et al.
Publicado: (2022)

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704
por: Regine, William F., et al.
Publicado: (2018)

A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis
por: Grechukhina, Olga, et al.
Publicado: (2012)

TRLS-09. RTOG1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY IN COMBINATION WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM HER2-POSITIVE BREAST CANCER
por: Kim, In Ah, et al.
Publicado: (2019)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines
por: Chen, Chien P., et al.
Publicado: (2015)

Prostate Stereotactic Body Radiation Therapy With Halcyon 2.0: Treatment Plans Comparison Based on RTOG 0938 Protocol
por: Altundal, Yücel, et al.
Publicado: (2020)

Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients
por: Kim, Jinuk, et al.
Publicado: (2021)

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
por: Scheurer, Michael E, et al.
Publicado: (2022)

Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines
por: Croke, Jennifer, et al.
Publicado: (2014)

Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
por: Patil, Nirav, et al.
Publicado: (2021)

p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry
por: Fadare, Oluwole, et al.
Publicado: (2017)

Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers
por: Velker, Vikram M, et al.
Publicado: (2013)

Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy
por: Pokhrel, Damodar, et al.
Publicado: (2016)

Planning quality and delivery efficiency of sMLC delivered IMRT treatment of oropharyngeal cancers evaluated by RTOG H‐0022 dosimetric criteria
por: Zhu, X. Ronald, et al.
Publicado: (2004)

Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
por: Mitra, Devarati, et al.
Publicado: (2017)

Differences in lower cranial nerve complications predicted by the NTCP model between RTOG and reduced-volume IMRT planning in radiotherapy for nasopharyngeal carcinoma
por: Qian, Jianjun, et al.
Publicado: (2020)

Quantitative assessments of late radiation-induced skin and soft tissue toxicity and correlation with RTOG scales and biological equivalent dose in breast cancer
por: Huang, Y., et al.
Publicado: (2021)

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
por: Lassman, Andrew B., et al.
Publicado: (2022)

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
por: Batchelor, Tracy T, et al.
Publicado: (2023)

Normalized “medical inferiority bias” and cultural racism against international medical graduate physicians in academic medicine
por: Smith, Stephen M., et al.
Publicado: (2023)

Estrogen withdrawal, increased breast cancer risk and the KRAS-variant
por: McVeigh, Terri P, et al.
Publicado: (2015)

Technical note: The effect of the 4‐mm‐collimator output factor on gamma knife dose distributions
por: Gibbons, John P., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_t8n1dnt93r71734kb6uae2s9v0